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ABSTRACT 
Familial adenomatous polyposis (FAP) is a rare hereditary condition with a high risk of 
gastrointestinal cancer. Individuals with FAP are committed to endoscopic screening 
surveillance throughout life in addition to having to undergo removal of the colon. With 
the intention to find strategies to develop care and support, the overall aim was to gain a 
deeper understanding of the life of surgically treated individuals with FAP. The first study 
used focus group interviews to collect data. The sample consisted of 14 surgically treated 
individuals, aged 18-75. Studies II-IV employed a cross-sectional design and were based 
on self-reported standardized questionnaires to measure abdominal symptoms, health-
related quality of life, illness perceptions and quality of care. Assessments were performed 
using the Abdominal Symptom Questionnaire (ASQ), the Medical Outcomes Study Short 
Form 36 Health Survey (SF-36), the Revised Illness Perception Questionnaire (IPQ-R) 
and the Quality of Care from the Patients Perspective (QPP). The sample consisted of 209 
surgically treated individuals, aged 18-75 (response rate 76%). The focus group interviews 
revealed that surgically treated individuals’ have several concerns, including issues about 
hereditary, the life-long nature of their illness and abdominal symptoms. Individuals use 
different strategies to minimize the effects of their illness on everyday life. The results 
from the self-reported questionnaires revealed that 91% of the individuals perceived at 
least one abdominal symptom during the past three months and reported a mean of 7 (SD 
4.61; range 1-18) symptoms. A high number of abdominal symptoms predicted poorer 
health status. Furthermore, individuals perceived FAP as chronic and to a low extent 
possible to control. Negative consequences of the illness predicted a worse HRQL as did 
number of abdominal symptoms. Individuals receiving specialized care and those with a 
low number of abdominal symptoms were more likely to perceive the quality of care they 
received as better. In conclusion, to improve HRQL abdominal symptoms and negative 
consequences on life should be monitored and self-care supported when caring for 
surgically treated individuals with FAP. Care should be provided by a team of health-care 
professionals specialized in FAP and is recommended to be coordinated by a nurse. Such 
care should be holistic and focus on supporting the self-care of the individual.    
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1 INTRODUCTION 
Familial adenomatous polyposis (FAP) is a hereditary illness that, without prophylactic 
removal of the colon, is associated with an almost 100% risk of developing cancer. 
Individuals with FAP are free of symptoms before surgery, but often perceive 
symptoms related to impaired bowel function after surgery. Prophylactic surgery is 
therefore commonly expressed as the time point when individuals with FAP realize that 
they actually have an illness. When I was employed at the national Swedish Polyposis 
Registry (a competence center for hereditary polyposis syndromes, including a registry 
database and an outpatient clinic), in 1999, I had provided care for a few individuals 
with FAP at the surgery ward where I previously worked. Since I started to work at the 
Swedish Polyposis Registry I have provided care for approximately 100 surgically 
treated individuals with FAP. In addition, I have recorded all data into the Swedish 
Polyposis Registry, which means that I have read thousands of medical records the last 
ten years for additionally 250 individuals. Finally, as the coordinator of the Swedish 
Polyposis Registry, I have been communicating with persons (patients, relatives and 
health-care providers) throughout the country. All this has given me an insight into how 
it can be to live with FAP, as well as uninvestigated areas that seemed to affect an 
individuals’ life. Issues of concern were related to care given by health care providers 
who have no or little knowledge of FAP, the lifelong endoscopic surveillance program 
and non-specific abdominal symptoms not previously investigated. I found that care for 
surgically treated individuals with FAP was not similar for all persons, i.e. it seemed 
that care was more dependent on where in the country the person lived than on the 
actual care needed. At the planning stage of this thesis, there was consensus in the 
Western world regarding the medical management of FAP. However, consensus 
regarding the management of an individual’s everyday life after surgery, including 
symptom management, was not available because of a lack of research in this area. 
Furthermore, there were no Swedish reports published on psychosocial concerns in 
surgically treated individuals with FAP and there were almost no international 
publications. Nevertheless, it was generally accepted that individuals with FAP suffer 
from symptoms related to bowel dysfunction after surgery though knowledge as to how 
the symptoms affect life was limited. During the work of this thesis, studies that have 
been published are mainly in the field of genetic counseling and about young adults 
with FAP. In addition, one thesis studied the psychosocial and behavioral impact on 
FAP.  
 2 
2 CHRONIC ILLNESS EXPERIENCE 
Defining chronic illness is complex in that it is dependent on the person’s experience of 
an illness. Concepts included in the chronic illness experience vary. For instance, 
researchers with a psychology background will base their research on psychological 
implications associated with the illness, whereas sociologists will focus on behavioral 
implications while anthropologists investigate the experience of chronic illness in a 
social, cultural and ethnic context (1). Many of the criteria used to define chronic 
illness experience overlap each other and the differences are more a matter of the 
language used. Further, the chronic illness experience is too complex to define easily 
because of the different ways that individuals identify their chronic illness. Just because 
two individuals have the same chronic disease, does not necessarily mean they view the 
illness similarly (e.g., one of them may not even view his or her disease as chronic) (1). 
One definition that takes the illness experience into account from a nursing perspective 
was formulated by Curtin and Lubkin (2), who stated, “Chronic illness is the 
irreversible presence, accumulation, or latency of disease states or impairments that 
involve the total human environment for supportive care and self-care, maintenance of 
function, and prevention of further disability”. In the context of nursing, chronic illness 
experience is further based on a holistic and patient-centered view, which is based on 
the understanding of patients’ illness experiences (3). Criteria usually included in the 
chronic illness experience are lack of control, self-care (4), adaptation, powerlessness, 
social isolation, sexuality, quality of life and adherence (5). In addition, how 
individuals view themselves as chronically ill is dependent on the family and the social 
and health care context (1, 5). Self-care has been described as taking control over the 
disease, with the aim of living a life as normal as possible. To stay in control 
individuals monitor their body for signs of illness, or what Thorne and colleagues have 
called, “body listening” (4). Although there is no uniform definition of self-care, Hertz 
(6) developed a working definition based on diverse perspectives of the concept. The 
working definition states, “self-care is self-determined, unique to each individual based 
on that person’s life experience, values, beliefs, and personal characteristics and 
abilities, including biopsychosocial-spiritual and functional abilities. Self-care includes 
a variety of activities, including adherence to prescribed medical treatments and 
guidelines for disease prevention, as well as pursuing personal interests that promote 
well-being (6).  
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2.1 SYMPTOM EXPERIENCE  
The word symptom can be traced to its Latin origin, “synthoma” meaning ‘sign of 
something evil’ (7). Today, symptom is defined as “a change in your body or mind that 
shows that you are unhealthy” (8) and further, a private experience unknown by others 
(9). An individual’s experience of a symptom is thought to include symptom 
occurrence, frequency, intensity, distress and meaning of symptoms, including the 
situational and existential meaning of individual symptoms as well as the impact of 
symptom clusters (10). A symptom experience is influenced by antecedents, such as 
demographic (e.g., age, gender and marital status) and individual characteristics (e.g., 
health knowledge, values and experiences) and disease characteristics (e.g., type of 
treatment and clinical factors) (10). In the context of FAP symptoms (which are caused 
by the prophylactic colorectal surgery aiming to prevent colorectal cancer) that are 
related to an impaired bowel function are an everyday concern (11).  
 
2.2 ILLNESS REPRESENTATION 
Individuals with a chronic illness are considered to adapt an illness behavior that is 
needed to improve or maintain health, as well as to accommodate their own and 
societal expectations. In the common sense model of self-regulation (CSM) constructed 
from in-depth interviews with patients to elicit illness representation, symptoms are the 
individual’s concrete representations of illness (12). Three principles underlie CSM: 1) 
individuals are problem solvers who seek information and adequate actions, 2) the 
individual’s illness representation guides actions (coping) and evaluation of action 
outcomes and 3) illness perceptions are individual and may not necessarily correspond 
to medical facts (13). When persons perceive a health threat (e.g., a media message 
about swine flu or symptoms of an illness), they have to deal with two phenomena: the 
individual’s perception of a health threat and the emotional reactions to the threat. The 
two phenomena operate in parallel and are partly independent in that they may motivate 
the same behavior or may motivate contrasting behaviors (13, 14). The illness 
representation evolves and will be more detailed and rich with increasing experience 
and knowledge, which results in a more reliable influence on the patient’s behavior 
(15). The Revised version of the Illness Perception Questionnaire (IPQ-R), which has 
been used in patients with a variety of diagnoses, was developed to assess illness 
perception (16).  
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2.3 QUALITY OF CARE 
Health care is integrated with the individuals’ self-care actions because quality of care 
is a part of their self-care recourses (6). Good outcomes are believed to be a result of 
productive interactions between the individual and the health care providers, where 
both the individual and the health care providers need to be active (17, 18). It has been 
suggested that nurse practitioners or specialized nurses are able to assume a leadership 
role in the health system transformation for chronic disease care because nursing’s 
disciplinary is based on a holistic, individualized care (6, 18). A model that considers 
the patient-provider relationship is in line with the framework of Wilde and colleagues 
(19) in which quality of care from the patients’ perspective is underlined. Based on 
interviews with adult hospitalized patients, they formulated a model in which quality of 
care could be understood. The model comprises the patient’s preferences and qualities 
related to the physical and administrative care environment. The individuals’ 
preferences refer to rational aspects (e.g., their ambition for predictability and 
calculability in life) and human aspects (e.g., their expectations that their unique 
situation will be taken into account). The qualities related to the physical and 
administrative care environment refers to person-related qualities of the caregivers and 
infrastructural components (e.g., organizational rules and technical equipment) (19). 
Individuals’ perception of quality of care can be considered from four dimensions: 
medical-technical competence, physical-technical conditions, identity-oriented 
approach and socio-cultural atmosphere. Medical technical competence refers to the 
patient’s wishes that caregivers possess a high level of medical-technical competence, 
i.e. qualified personal who can make correct diagnoses, propose relevant examinations 
and alleviate symptoms. It also includes wishes of having access to caregivers with a 
high level of medical-technical competence. Physical-technical conditions refer to the 
availability of a care organization providing the necessary physical-technical 
conditions, such as a clean, comfortable and safe environment, as well as advanced 
medical-technical equipment. The identity-oriented approach denotes the human aspect 
of the patient’s relationship to caregivers, such as the wish of qualified caregivers with 
an interest in the patient as a unique person as well as a wish for mutual understanding, 
respect and collaboration between caregivers and patient. The socio-cultural 
atmosphere pertains to a human environment that includes a care organization that 
allows an individual’s wishes and needs to be prioritized before fixed routines and 
where the individual can choose to socialize or not depending on mood and state of 
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mind (19). The model has been operationalized to be assessed with the questionnaire 
Quality of Care from the Patients’ Perspective (20). 
 
2.4 HEALTH-RELATED QUALITY OF LIFE 
In 1948, the World Health Organization (WHO) (1948) presented a broad definition of 
health: “a state of complete physical, mental and social well-being and not merely the 
absence of disease or infirmity”. A definition provided in the context of self-care in 
chronic illnesses is in line with the WHOs definition (21). Hertz (6) stated that “health 
is holistic, meaning that it is more than the absence of physical and mental health” and 
that “health and chronic illnesses can coexist”. Health-related quality of life (HRQL) is 
an outcome measure to evaluate the impact of an illness on an individual, assess 
response to treatment and guide interventions (6, 22). Although no consistent definition 
exists, general health, physical functioning, physical symptoms, emotional functioning, 
cognitive functioning, role function, social well-being and sexual functioning are areas 
generally included in HRQL (23). Eight health concepts provided by Ware and 
colleagues (24) will be referred to as HRQL in this thesis: 1) limitations in physical 
activities because of health problems, 2) limitations in social activities because of 
physical or emotional problems, 3) limitations in usual role activities because of 
physical health problems, 4) bodily pain, 5) general mental health (psychological 
distress and well-being), 6) limitations in usual role activities because of  emotional 
problems, 7) vitality (energy and fatigue) and 8) general health perception. Given the 
broad concept of health and HRQL the measurement of the concepts varies (23). The 
most widely used questionnaire is the Short-Form Health Survey (SF-36), which was 
designed to assess generic health concepts that are not specific to age or disease (24). 
 6 
3 BACKGROUND 
 
3.1 HISTORICAL OUTLINE 
In 1953, at St Erik’s Hospital in Stockholm ‘diffuse adenomatosis’ was suspected in a 
44-year-old male who underwent surgery for colon cancer. The individual had a 
desmoid tumor (locally infiltrating and occasionally life-threatening lesion) and 
epidermoid cysts known to be associated to clinical manifestations with, what later 
would be named, ‘familial adenomatous polyposis’. The individual was finally given 
the correct diagnosis in 1961(25). Inspired by the work of Dukes (26), the first attempts 
were made to trace Swedish families with FAP. Finally, in 1959, the Swedish Polyposis 
Registry at St Erik’s Hospital was established (25). The primary aim of the registry was 
to prevent colorectal cancer in persons with FAP in the family (26). The organization 
and outline of the registry were based on the work of the Polyposis Registry at St 
Mark’s Hospital in London, which was set up already in 1925 (27). The familial 
occurrence of the disease was observed already in the latter half of the 19th century, but 
the heritage was first verified in 1952 by Dukes (26) when he analyzed a larger number 
of families. Two theses have been conducted at the Swedish Polyposis Registry. The 
first thesis was undertaken by the physician Thor Alm (25) with the aim of gathering all 
individuals with FAP in Sweden to calculate incidence, set up a registry and evaluate 
the results of surgical treatment. At that time, the Swedish Polyposis Registry included 
80 fully investigated families (25). The second thesis, by the physician Jan Björk, 
included the evaluation of the efficiency of the national screening program in reducing 
the risk of colorectal cancer in individuals with FAP. The results are based on data 
between 1957 and 1996 (28). In 1996, the number of families with FAP in the registry 
had increased to 145 (29). The present thesis contributes to the knowledge of FAP by 
increasing the understanding of the impact on the lives of surgically treated individual’s 
with FAP.  
 
3.2 GENETICS 
DNA (Deoxyribonucleic acid) contains all information needed when building a person. 
A mutation, which is the cause of genetic diseases, is a change in the individual’s DNA. 
If the DNA is the sentence that gives information about how to build, the mutation can 
be seen as a spelling error. A spelling error (mutation) can give the sentence a different 
meaning, which may cause illness. FAP is inherited in an autosomal dominant way, 
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which means that a child of a parent with FAP has a 50% risk of inheriting the 
syndrome (29) (Figure 1). The gene was identified in 1991 and is called the 
adenomatous polyposis coli (APC) gene (30). In 2000, another polyposis gene, the 
MUTYH gene was identified. This form of polyposis is called MUTYH-associated 
polyposis (MAP) and the mode of inheritance is autosomal recessive (31). This means 
that for a child with a parent with MAP the risk of inheriting the syndrome is 
approximately 0.25% since the frequency of heterozygous mutation carriers in the 
background population is about 1/100. (31). Molecular genetic testing has failed to find 
disease-causing mutation in approximately 10% of the Swedish polyposis families with 
clinical evidence of disease, indicating that more genes might be involved in causing 
the illness. In addition, approximately 10% of all FAP individuals have been reported 
to be “de novo” without clinical or genetic evidence of FAP in the parents (29).  
 
 
 
 
 
 
 
 
 
 
 
 
3.3 INCIDENCE AND PREVALENCE 
FAP is responsible for approximately 0.1% of all colorectal cancer cases. In Sweden, 
about 350 persons live with FAP, yielding a prevalence of 35 per 1000 000 inhabitants. 
Annually, 7-8 children are born with FAP in Sweden (29). The incidence and 
prevalence of FAP are similar in the Western world (32). Because our knowledge of 
MAP is relatively new, incidence and prevalence have not been fully investigated. 
 
3.4 CLINICAL CHARACTERISTICS 
FAP is characterized by the development of hundreds to thousands of adenomas in the 
colorectum (33). Mortality from colorectal cancer is assumed to be almost 100% 
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without treatment (colorectal surgery), and half of the individuals diagnosed with FAP 
would die of cancer before the age of 50 (34). There is also an increased risk of cancer 
in the duodenum (35). An increased risk of hepatoblastoma, as well as thyroid cancer 
and medulloblastom in individuals with FAP has also been reported (32). Furthermore, 
FAP is associated with extraintestinal manifestations, such as desmoid tumours (locally 
infiltrating and occasionally life-threatening lesions mostly located in the abdominal 
cavity or abdominal wall), epidermoid cysts (benign cysts appearing as a bump on the 
skin), cutaneous lipomas and osteomas (32). The characterization of MAP is similar to 
FAP, although MAP is considered less severe than FAP in age of onset, numbers of 
colorectal adenomas and extraintestinal manifestations (32, 36). Because our current 
knowledge about the nature of MAP is limited, treatment and follow-up of individuals 
with MAP are similar to FAP in Sweden (36). Henceforth, in this thesis all individuals 
will be referred to as patients with FAP.  
 
3.5 DIAGNOSIS 
All individual with a risk of FAP, with the exception of families in which no mutation 
is found, are offered genetic testing (blood sample) to confirm or deny a diagnosis of 
FAP (32). For children with a history of FAP in the family, screening starts at the age 
of 10-12 years with a genetic test or with colonoscopy if a genetic test is not possible 
(32). Children with a verified diagnosis, either because of the finding of a disease 
causing mutation or by identified adenomas in the colon or rectum, will be followed 
annually with colonoscopy until prophylactic colorectal surgery is performed (32).  
 
3.6 GENETIC COUNSELING 
All genetic testing shall be preceded by genetic counseling, which is delivered by 
different health professionals (e.g., physicians, nurses, psychologists) educated in 
genetic counseling. In Sweden, most genetic counselors are affiliated to a genetic clinic 
at University Hospitals. A genetic counseling session includes the following: taking 
family medical history, providing information about the inheritance and risk for family 
members, collecting blood samples for testing and processing result disclosure. It is 
important that genetic counselors support the individual to make an informed choice 
about testing, so that individuals know what a positive or negative result means for 
them and for close family members (37). Testing for genetic illnesses is associated with 
concerns and can be stressful before test disclosure (37). However, there are both 
positive and negative aspects of genetic testing when interviewing young people who 
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had undergone genetic testing for FAP (38). Participants felt empowered and family 
relationships were improved (38); however, lack of control and involvement in the 
decision to be tested were also discussed (38, 39). Another important function for 
genetic counselors is to support individuals in family planning. Having FAP has been 
found to influence an individual’s desire to have children. However, termination of 
pregnancy has not been seen as an alternative (40, 41), whereas a person is more 
positive to prenatal diagnosis (test for disease in a embryo before it is born) in order to 
prevent having a child with FAP (41). Furthermore, parents have been found to prefer 
FAP testing in children at birth or early childhood instead of waiting 10-12 years 
according to guidelines (40, 41). Genetic counseling is recommended at time for 
genetic testing (32), although regular follow-up in young adults after test disclosure has 
been suggested in order to provide support, especially in family planning (40).  
 
3.7 TREATMENT AND OUTCOMES 
 
3.7.1 Prophylactic surgery 
To prevent colorectal cancer prophylactic surgery is normally performed between the 
ages of 18 and 20 years, with removal of the colon (colectomy) or colorectum 
(proctocolectomy). The two most common prophylactic colorectal surgical procedures 
in individuals with FAP are ileorectal anastomosis (IRA) and ileal pouch anal 
anastomosis (IPAA). When IRA is performed, the large intestine is removed and the 
ileum is anastomosed to the rectum. To create an IPAA, both the large intestine and 
rectum are first removed and the last part of the ileum is turned into a pouch, which is 
sewn onto the anus (42). A third, less common, method of surgery to prevent colorectal 
cancer in FAP individuals is through the creation of a permanent ileostomy. In 
ileostomy the large intestine is removed and the ileum is then attached to the abdominal 
wall (stoma) (43). The lifetime risk of additional operations (IPAA or permanent 
ileostomy) because of advanced polyposis or cancer in the remaining rectum or pouch 
is high, up to approximately 70% (30). There is also a risk that individuals will need 
further surgery because of polyposis or cancer in the duodenum (34). Preliminary data 
from the Swedish Polyposis Registry show that by the age of 60, 15% of the 
individuals have had their duodenum prophylactic removed.  
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3.7.2 Endoscopic surveillance 
Prophylactic surgery is followed by lifelong endoscopic surveillance. Individuals with 
IRA undergo examination of the rectum every 6 months, whereas patients with IPAA 
undergo examination of the pouch every 24 months (32). The procedures are similar: a 
long, flexible, lighted tube is inserted into the intestine through the anus and the lining 
of the intestine is visible in a TV monitor to all persons in the room. Removal of polyps 
is possible since the endoscope permits passage of an instrument with forceps at the 
end. To perform a high quality examination the intestines need to be empty before the 
examination. Thus, individuals need to prepare with bowel cleaning prior to the 
examination. Because of the risk of severe polyposis or cancer in the duodenum, 
investigation of the stomach and the duodenum (esophagogastroduodenoscopy, EGD) 
is recommended from the age of 25 (32, 35). EGD is a procedure in which the patient 
swallows a thin, flexible, lighted tube, which allows viewing the lining of the 
esophagus, stomach and duodenum on a TV monitor. To perform a safe and high 
quality examination at the same time the stomach should be empty. Consequently, the 
individual needs to be without food and drink six hours before the procedures. 
Surgically treated individuals with FAP are probably those that undergo most 
endoscopic examinations during their life (e.g., an individual with IRA undergoes 
examination of the rectum every 6 months). In addition, examination of the stomach 
and duodenum (EGD) is performed every 24 months or even more frequently 
depending on the examination findings. Endoscopic examinations in patients are often 
associated with discomfort and anxiety. However, the impact of frequent endoscopic 
surveillance, as in the case with surgically treated individuals with FAP, has not been 
investigated. Because of the high risk of cancer, it is important that individuals with 
FAP consider recommended endoscopic intervals (44). Yet, knowledge about 
adherence among surgically treated individuals with FAP is limited. One study found 
that non-adherence to endoscopic screening in individuals with an IRA was 26% (45). 
Another study found that 48% of individuals with a positive mutation for FAP or 
individuals who had undergone prophylactic surgery to be non-adherent (46). 
Suggested factors related to non-adherence are individuals’ perception of having a low 
risk of cancer, lack of provider recommendations, deficiency or absence of health 
insurance (46), fear of additional surgery, social inconvenience and young adulthood 
(44). 
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3.7.3 Complications related to surgery 
Individuals with FAP are normally asymptomatic before surgery, but it is well known 
that bowel function is impaired after surgery (11). Reported symptoms related to 
impaired bowel function are increased defecation frequency, nighttime defecation, 
leakage, difficulty in distinguishing gas from feces, perianal skin problems, 
symptoms of small bowel obstruction and dietary restrictions (11, 47, 48). Individuals 
with their rectum removed (IPAA) often report more symptoms than those who have 
undergone colectomy without removal of the rectum (IRA) (11, 49). Further, 
knowledge of perceived bowel function in individuals with an ileostomy is limited 
(50). Nevertheless, one study showed that individuals with an ileostomy perceived 
having an excellent bowel function; however, the result was based on interviews with 
only 10 individual (50), which must be considered as a limitation. In addition, 
knowledge of an individual’s perception of bowel function, as well as what 
abdominal symptoms trouble them after removal of the duodenum is limited, 
although pain has been reported (51). Furthermore, impairment in sexual function, 
such as diminished libido and/or erection in males and dyspareunia in females, has 
been reported (48). Moreover, fecundity in women has been found to decrease after 
IPAA surgery, whereas no impact on fecundity in women with IRA has been reported 
(52).  
 
3.7.4 Health-related quality of life in individuals with FAP 
Quality of life research in individuals with FAP has mainly focused on the impact of 
bowel function and surgery. Efforts have been made to determine which type of 
surgery is most beneficial for the individual. However, inconsistent results have been 
found, making it difficult to recommend one type of surgery over another (11). Quality 
of life in surgically treated individuals with FAP has been reported to be in parity with 
population norms (47-49, 53,54). Nevertheless, some studies have found associations 
between quality of life (53), or aspects of quality of life (34, 55), and bowel function. 
Further, different effects on specific aspects of quality of life have been noted, such as 
physical functioning, changes in body image, employment and sexual impact (54-56). 
One study indicates that individuals with FAP and desmoid tumor perceive a reduced 
quality of life (57). Moreover, surgical complications and comorbidity have been found 
to be associated with reduced quality of life (54). Further, guilt regarding the risk of 
passing on the disease to their offspring (58), fear and anxiety about future health 
because of the risk of cancer has been reported (58, 59). FAP related stress has been 
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found in a minor group of individuals (55, 59), why a screening questionnaire to 
identify individuals who need support has been recommended (59). In addition, 
supportive counselling is considered important both before and after surgery (54, 55).  
 
3.8 FAP CARE IN SWEDEN 
 
The organization of the Swedish Polyposis Registry consists of a computerized 
database, the outpatient clinic and the endoscopy unit. Today, the Swedish Polyposis 
Registry includes 240 families (236 with FAP and 4 with MAP). Of the 600 persons in 
the registry with FAP (or MAP), 350 were still alive at the time of the present study. 
Data on family history, genetic status, extraintestinal manifestations, surgery and 
endoscopic examinations, including pathology reports, are included in the registry. 
Registry data are obtained from the patient medical records. The Swedish Polyposis 
Registry is a database for research, and assists with family investigations and 
information to patients, relatives and health care providers throughout the country. In 
addition, the registry organizes a yearly nationwide education day for patients and 
relatives. At the time of the present studies, the outpatient clinic that is affiliated to the 
Swedish Polyposis Registry provided specialized care based on a team of one 
consultant and one specialized nurse; the latter also serves as a genetic counselor. Since 
then, the team has expanded to include two consultants and two nurses. One important 
aim is to provide continuity and individualized care by coordinating and performing all 
endoscopic examinations and providing individualized regular appointments to 
consultants, nurses and the genetic counselor. The outpatient clinic coordinates care for 
approximately 30% (n=110) of the Swedish population with FAP. The primary 
catchment area is Greater Stockholm with a population of approximately 2 million 
inhabitants; health care for most of the remaining FAP individuals in Sweden is 
provided by the hospital in the county council where the patient resides. At time of this 
study, individuals included in the study (n=153) from outside the Swedish Polyposis 
Registry clinic were managed by approximately 75 physicians (median=1, range 1-6) at 
34 hospitals (7 university hospitals; data obtained from the Swedish Polyposis 
Registry). When scrutinizing medical records for those individuals, organization of the 
care process was found to vary between hospitals. The outpatient clinic at the Swedish 
Polyposis Registry offers second opinion consultations and genetic counseling for 
individuals outside its catchment area. A referral from their county council is needed, 
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however. The possibility for an individual with FAP to have a referral for a second 
opinion varies.  
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4 THESIS RATIONALE 
 
Previous studies investigating the influence on life in surgically treated individuals with 
FAP have focused on symptoms related to impaired bowel function. The studies have 
been limited to two of three surgical procedures that are usually performed to prevent 
colorectal cancer. The sample sizes are often small and typically include heterogeneous 
samples (e.g. patients FAP and inflammatory bowel disease). Furthermore, findings 
from studies pertaining to quality of life and psychosocial issues are often based on 
samples with a mix of surgically treated individuals with FAP, patients diagnosed with 
FAP without surgery and individuals with a risk of FAP. Moreover, knowledge of how 
surgically treated individuals perceive their illness is therefore limited (e.g., HRQL, 
abdominal symptoms, endoscopic surveillance) and no studies have been undertaken to 
investigate how individuals perceive the quality of care.  
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5 AIM 
With the intention to find strategies to develop care and support, the overall aim of this 
thesis was to gain a deeper understanding of the lives of surgically treated individuals 
with FAP. This overall aim was approached with the following specific aims:  
 
I. To gain a deeper understanding of how FAP affects life by exploring 
patients’ views of what it is like living with the condition and having to be 
committed to a lifelong screening program. 
 
II. To investigate self-reporting by adults with FAP with regard to presence, 
frequency and troublesomeness of abdominal symptoms in relation to health 
status. An additional aim was to study abdominal symptoms in relation to 
gender and type of colorectal surgery. 
 
III. To examine how patients with FAP perceive their illness and experience 
HRQL. Additional aims were to examine how illness perceptions and 
HRQL may differ between subgroups of patients in gender, family history 
of FAP and adherence to treatment. A further aim was to investigate 
whether any socio-demographic and clinical variables (including number of 
abdominal symptoms) and illness perceptions are associated with HRQL. 
 
IV. To test the hypothesis that surgically treated patients with FAP who receive 
specialized care rate quality of care more favorably than patients who 
receive non-specialized care. An additional aim was to investigate whether 
any socio-demographic and clinical variables are associated with quality of 
care.  
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6 METHODS 
 
6.1 DESIGN 
Study I is a descriptive qualitative study based on data obtained by focus group 
interviews. Studies II-IV used a cross-sectional, cohort design. Study outcomes, 
participants, data collection and analyses are presented in Table 1.  
 
Table 1. Overview of outcomes, participants, data collection and analyses within this 
thesis 
Study Outcomes Participants Data collection Analyses 
I Patients view of what 
it is like living with 
FAP 
14 patients,  
age 28-67 
 
Focus group interviews χ2 tests, 
Descriptive 
content analysis 
II Number, frequencies 
and troublesomeness 
of abdominal 
symptoms 
 
Abdominal symptoms 
related to bowel 
function 
 
Health Status 
 
Factors related to 
Health Status 
209 patients, 
age 18-75;  
93 men and 
116 women 
 
The Abdominal 
Symptom Questionnaire 
(ASQ) 
 
Five additional 
abdominal symptoms 
from the Revised Illness 
Perception 
Questionnaire (IPQ-R) 
 
The Short Form 36 
Health Survey (SF-36) 
 
 
χ2 tests, 
Independent t-
tests, One-way 
ANOVA, 
Pearson 
correlation 
coefficients, 3-
step hierarchical 
regression 
analyses 
III Illness perception 
 
 
 
Health Related quality 
of life (HRQL) 
 
Factors associated with 
HRQL 
The Revised Illness 
Perception 
Questionnaire (IPQ-R) 
 
The Short Form 36 
Health Survey (SF-36) 
 
The Abdominal 
Symptom Questionnaire 
(ASQ) 
 
 
χ2 tests, 
Independent t-
tests, Cronbach’s 
alpha 
coefficients, 3-
step hierarchical 
regression 
analyses 
IV Quality of Care 
 
 
 
Factors related to 
Quality of Care 
The Quality of Care 
from the Patients 
Perspective (QPP) 
 
The Abdominal 
Symptom Questionnaire 
(ASQ) 
 
χ2 tests, logistic 
regression 
analyses 
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6.2 PARTICIPANTS 
6.2.1 Study I 
Participants were recruited from the outpatient clinic at the national Swedish Polyposis 
Registry, Karolinska University Hospital, Stockholm. Forty-three of 90 patients 
fulfilled the criteria for participation. Inclusion criteria were aged 18-75 years, having a 
mutation in the adenomatous polyposis coli gene (APC) or meeting the criteria for 
classic FAP. Fourteen of the 43 patients invited agreed to participate (Table 2). 
 
Table 2. Participants’ characteristics (n=14) 
 mean (range) n 
Age      47 (28-67)  
Sex   
 Women   10 
 Men    4 
Marital status   
 Married/partnered  10 
 Single    4 
Participants having children    9 
Socio-economic status   
 Employed     7 
 Student     1 
 Disability pension*    2 
 Retired    4 
APC mutation  14 
New mutation    2 
   
Median time from diagnosis to study       25 (4-47)  
   
Type of surgery   
 IRA     6 
 IPAA    4 
 Permanent ileostomy    4 
Median time from surgery to study        24 (4-44)  
Second surgery   
 Permanent ileostomy    2 
Upper gastrointestinal surgery   
 Duodenectomy    2 
Desmoid tumour    1 
FAP associated cancer    3 
* Not due to FAP  
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6.2.2 Studies II-IV 
Participants were recruited from the national Swedish Polyposis Registry, Karolinska 
University Hospital, Stockholm. Patients eligible for inclusion were aged 18-75 years, 
having a mutation in the APC, or homozygote mutation in the MUTYH gene, or who 
met the criteria for classic FAP and who had prophylactic colorectal surgery. Two 
hundred seventy-six patients met eligibility criteria and thus were invited to participate 
in the study. One patient did not speak Swedish and was therefore excluded. A flow 
chart describing participants and non-participants is shown in Figure 1. Of 275 patients, 
209 (76%) consented to participate (Table 3).  
 
 
 
 
 
Original cohort 
n=291
Excluded  
n=16 
Eligible n=275 
Declined 
questionnaire   
n=66
Returned 
questionnaire 
n=209 (76%) 
Figure 1. Flow chart describing participants and non-participants 
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Table 3. Participants’ characteristics (n=209) 
 mean (SD; range) n % 
Age       49  (14; 18-75)   
Sex    
 Men       48  (15; 18-75)   93 44 
 Women       49  (13; 23-74) 116 56 
Living situation    
 Partnered  139 67 
 Single     61 29 
 Living with parents or other      9   4 
Occupational status    
 Working  123 59 
 Student    12   8 
 Retired    42 20 
 Disability pension    17   8 
 Sick-listed    11   5 
Participants having children  144 69 
Educational attainment    
 Compulsory school    56 27 
 High-school (2 years)    37 18 
 High-school (3 years)    33 16 
 High-school (4 years)      7   3 
 Post graduate school    27 13 
 University    45 22 
Family history of FAPa    169 81 
Mutation    
 APC  158 76 
 MYH      7   3 
 Mutation not found    23  11 
 Not tested    21 10 
Age at diagnosis         26  (12; 3-57)   
Age at first colorectal surgery, years         28  (11; 5-58)   
Time since first colorectal surgery to study, years         21  (12; 1-50)   
Times since last colorectal surgery to study, years         14  (10; 1-50)   
First colorectal surgery    
 IRAb  126 60 
 IPAAc    47 23 
 Ileostomy    22 11 
 Continent ileostomy    10   5 
 Other     4   2 
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Table 3. continued  n % 
Second colorectal surgery    
 IPAA    39 19 
 Ileostomy    22 11 
 Content ileostomy      6   3 
Third colorectal surgery    
 Ileostomy      4   2 
Colorectal surgery at time for study     
 IRA    71 34 
 IPAA    82 39 
 Ileostomy    39 19 
 Continent ileostomy    14   7 
 Other      3   1 
Total number of colorectal procedures   
 One   132 63 
 Two    66 32 
 Three or more    11   5 
Upper gastrointestinal surgery    12   6 
 Whipple procedure    11   5 
 Duodenectomy    
Desmoid tumor    20 10 
FAP related cancer 
 Intestinal cancer    29 14 
 Extraintestinal cancer    11   5 
 Intestinal and extraintestinal cancer    10   5 
Adherence to endoscopic surveillance    
 Adherent  180 86 
 Non-adherentd    29 14 
Organization of care    
 Specialized caree    57 27 
 Non-specialized care  152 73 
a Participants has family members with FAP 
bIRA=ileorectal anastomisis 
cIPAA=ileal pouch anal anastomosis 
dNo record of endoscopic surveillance one year later than recommended intervals 
eThe outpatient clinic affiliated to the national Swedish Polyposis Registry, Karolinska University 
Hospital 
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6.3 DATA COLLECTION 
6.3.1 Focus group interviews (Study I) 
In study I data were collected using focus group interviews. Issues described in the 
literature as affecting the lives of patients with FAP as well as topics recognized in 
practice as important were formed into possible statements and questions to guide 
discussions in the event patients themselves did not raise any issues (Figure 2). The 
identified areas were FAP’s impact on the life of the patient, hereditary aspects and the 
effects of prophylactic colorectal surgery and endoscopic surveillance on FAP patients.  
 
6.3.2 Instruments (Studies II-IV) 
The Abdominal Symptoms Questionnaire (ASQ) was used to measure abdominal 
symptoms (60) (Studies II-IV). The original ASQ is divided into three parts, of which 
only the first part was used in this thesis. This part includes 21 items measuring the 
presence of general abdominal symptoms. Respondents were asked to indicate the 
presence or absence (yes/no) of selected symptoms over the past three months as well 
as their frequency (“every day”, “every week” or “every month”). The respondents 
were also asked to rate the troublesomeness of the symptoms on a seven-point Likert-
style scale with the anchors “mild” and “very severe”. The complete ASQ was 
originally designed to identify three functional gastrointestinal disorders: dyspepsia, 
gastroesophageal reflux symptoms (GERS) and irritable bowel syndrome (IBS). The 
instrument has shown acceptable sensitivity and specificity in identifying persons with 
dyspepsia and IBS (60). In the present study troublesomeness of symptoms was 
calculated by adding the score (possible score 1-7) for all symptoms and dividing the 
sum by the number of reported symptoms. Example of question format and responses 
available in the ASQ (Figure 2) 
 
 
 
 
 
 
 
 
 
Figure 2. Example of question format and responses available in the ASQ 
The Abdominal Symptom Questionnaire (ASQ) 
Have you been troubled by abdominal distension during the last three months? 
 
Yes    No    
If yes: 
Every day    Every week  Every month     
 
Severity: 
Mild   Very severe 
2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
i al Symptom Questio naire (ASQ) 
 en troubled by abdominal distension during the last three months? 
Yes  No  
If yes: 
Every day  Every week  Every month   
 
Severity: 
Mild   Very severe 
 
   
Figure 4. Example of question format and responses available in the ASQ 
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The SF-36 was used to measure HRQL (24). The instrument consists of 35 items 
measuring eight dimensions: Physical functioning (PF), Role-physical (RP), Bodily 
pain (BP), General health (GH), Vitality (VT), Social functioning (SF), Role-emotional 
(RE) and Mental health (MH). In addition, one single item determines perceived 
differences in health status over the past year. Response choices vary from two to six. 
Twenty items refer to the four previous weeks, one concerns health transition over the 
past year and fifteen pertain to the present situation. Raw scores for each item were 
coded, summed and transformed into a scale from 0 (worst possible health status) to 
100 (best possible health status) following standard SF-36 scoring algorithms (24). 
Based on the eight scales, two summary scales have been constructed for physical and 
mental health: the physical component summary (PCS) and the mental component 
summary (MCS). The PCS is primarily a measure of PF, RP, BP and GH, whereas the 
MCS mainly encompasses VT, SF, RE and MH (61).The Swedish version has shown 
satisfactory results for reliability and validity (61, 62). 
 
The Revised Illness Perception Questionnaire (IPQ-R) was used to measure the 
participants’ beliefs and understanding of their illness perceptions (16). The instrument 
includes nine components: Timeline-chronic (6 items; e.g.,  “My condition is likely to 
be permanent rather than temporary”), Timeline-cyclic (4 items; e.g., “My symptoms 
come and go in cycles”), Consequences (6 items; e.g., “My condition has major 
consequences on my life”), Personal control (6 items; e.g., “The course of my condition 
depends on me”), Treatment control (5 items; e.g., “My treatment will be effective in 
curing my illness”), Emotional representation (6 items; e.g., “My illness makes me feel 
afraid ”), Illness coherence (5 items; e.g., “My condition is a mystery to me”), Causes 
(18 items), which measures a patient’s idea about the etiology of his or her condition 
(psychological, risk factor, immune and accident/chance), and an Identity component 
(see below). All items of the IPQ-R are rated on a five-point Likert scale ranging from 
“strongly agree” to “strongly disagree”, except the Identity component. Higher scores 
on the Timeline-chronic and Timeline-cyclical represent stronger beliefs that the 
condition is lasting or cyclical rather than acute in nature; higher scores on 
Consequences and Emotional representation represent stronger beliefs that the 
condition will have a negative impact on life; and higher scores on Personal control, 
Treatment control and Illness coherence constitute a positive belief about having 
control over the disease and finding treatment being effective as well as a greater 
personal understanding of the illness (16). The Identity component is measured by a 
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number of symptoms that patients are asked to evaluate in terms of whether they are a 
part of the illness (17 symptoms). On recommendation of the developers of the IPQ-R, 
Identity includes illness-specific symptoms as well as symptoms that are more general 
(e.g., fatigue and sleeping difficulties). Higher Identity scores indicate that a patient 
perceives a higher number of symptoms attributed to the illness. The IPQ-R has been 
found to yield adequate levels of validity and reliability (16). The Swedish version has 
shown good internal consistency and test-retest reliability (63). Example of questions 
format and responses available in the IPQ-R (Figure 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Example of questions format and responses available in the IPQ-R 
 
The Quality of Care from the Patients Perspective (QPP) was used to measure quality 
of care (20). The questionnaire includes four dimensions (the Medical-technical 
competence of the caregivers, the Physical-technical conditions of the care 
organization, the Identity-oriented approach and the Socio-cultural atmosphere of the 
care organization) and ten single items (64). The dimension Medical-technical 
competence of the caregivers includes medical care and waiting time. The dimension 
Physical-technical conditions of the care organization consists of care equipment, care 
room characteristics and means of communication. The dimension Identity-oriented 
approach of caregivers includes information before procedures, information after 
procedures, participation, responsible persons, respect, commitment, emphatic and 
The Revised Illness Perception Questionnaire (IPQ-R) 
 
Listed below are a number of symptoms (Identity scale) that you may or may not have experienced since your 
illness. Please indicate by ticking the appropriate box, whether you have experienced any of these symptoms since 
your illness, and whether you believe that these symptoms are related to you illness 
   
 I have experienced this  
symptoms since my illness 
This symptom is related  
to my illness 
 Yes No Yes No 
Upset stomach     
 
Please indicate how much you agree or disagree with the following statement about your illness by ticking the 
appropriate box. 
 
 
Views about your illness: 
Strongly 
disagree 
Disagree Neither agree  
nor disagree 
Agree Strongly 
agree 
My illness is a serious condition      
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personal. The dimension socio-cultural atmosphere of the care organization is made up 
of general atmosphere, secluded environment, family and friends and routines. All 
items included in the dimensions are evaluated in two ways. First, to measure the 
perceived quality of experienced care respondents are asked to indicate their level of 
agreement on a four-point Likert scale ranging from “strongly disagree” to “strongly 
agree”, or “not applicable”, except for the physical-technical conditions for which a 
dichotomous response format was chosen (yes/no). Second, to measure the subjective 
importance the person ascribes to the various aspects of care, they are asked to indicate 
their level of agreement on a four-point Likert scale ranging from “of little importance” 
to “of very great importance”. The single items included in the questionnaire measure 
physical and mental well-being, compliance to professional recommendations, access 
to health professionals and feelings about seeking care at the outpatient clinic in the 
future. For the purpose of this thesis, 25 items belonging to the four dimensions and 
eight 8 single items appropriate for outpatient care were selected. The phrasing of the 
items was altered to respond to patients’ perception of the quality of care in general 
instead of referring to a specific appointment as in the original version of the 
questionnaire. Example of question format and responses available in the QPP (Figure 
4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quality of Care from the Patients Perspective (QPP) 
Commitment How I think my care really was 
 Fully agree Mostly 
agree 
Partly 
agree 
Do not 
agree at all 
Not 
applicable 
I had the feeling that the nurses are 
interested in my concerns and hassles 
     
 
 This is how important it was for me 
 Of very 
great 
importance 
Of great 
importance  
Of some 
importance 
Of little 
importance 
Not 
applicable 
I had the feeling that the nurses are 
interested in my concerns and hassles 
     
 
Figure 4. Example of question format and responses available in the QPP. 
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Demographic and clinical characteristics (studies I-IV) 
Participants’ demographic and clinical characteristics were obtained from the national 
Swedish Polyposis Registry.  
 
6.3.3 Procedures 
Study I 
A letter was sent to those patients at the outpatient clinic at the national SPR that 
fulfilled the inclusion criteria. Sixteen patients agreed to participate in the focus group 
interview. The participants were divided into three groups by age. Group 1 included 
patients aged 20-30 years (n=4, one male), group 2 patients aged 31-50 years (n=6, one 
male) and group 3 patients aged 51 years and older (n=6, two males). However, two 
participants in the youngest group declined participation with short notice so group 1 
(age 20-30) finally included two participants (one male). The same moderator 
conducted all three focus group interviews. Interviews were carried out at the hospital 
after working hours; each interview lasted approximately two hours and was audio 
taped.  
 
Studies II-IV 
A letter was sent to those patients in the SPR that fulfilled the inclusion criteria. The 
letter included information about the study and contained a package of questionnaires. 
The letter highlighted that participation was voluntary and that non-participation would 
not affect a patient’s care or treatment. The patients who subsequently agreed to 
participate were asked to complete the package of questionnaires and return it in the 
enclosed postage-paid envelope. Patients who did not return the questionnaire were sent 
a reminder after three weeks. All returned questionnaires were read to detect missing 
data and participants were contacted by phone for completion of data when necessary.  
 
6.3.4 Data analyses 
Study I 
Data from the focus group interviews conducted in study I were transcribed verbatim 
and analyzed using a descriptive qualitative content analysis method (65). The analysis 
was performed in the following steps. (1) The transcribed material was repeatedly read 
to gain an overview, with words and sentences having similar meanings being 
identified and coded. (2) The codes were classified into categories that reflected their 
central content and the categories were then divided into sub-categories. (3) During the 
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analysis process, codes and content of the categories and sub-categories were discussed 
in the research group until final agreement was reached (65, 66).  
 
Studies II-IV 
Statistical calculations were performed using the Statistical Package for Social Sciences 
(SPSS) for Windows, version 17.0 (Studies II-III) and the IBM SPSS Statistics 19 
(Study IV). Demographic and clinical characteristics were presented with means and 
standard deviations or proportions. P-values <0.05 were interpreted to indicate 
statistical significance in studies II-III. To avoid false significant findings (type 1 error) 
because of calculations of several analyses in study IV p-values <0.01 were applied to 
indicate statistical significance. 
 
Study II 
Presence and frequency of abdominal symptoms are presented with the proportions. 
The overall troublesomeness of symptoms was calculated by adding up the scores 
(possible score, 1-7) for all symptoms and dividing the sum by the number of reported 
symptoms. Troublesomeness of abdominal symptoms is presented with mean and 
range. To investigate potential differences in mean values between groups independent 
t-tests and one-way analyses of variance (ANOVAs; gender and type of surgery as 
independent variables) were calculated. Relationships between variables (number of 
symptoms, perceived troublesomeness of symptoms, age and age at first and last 
surgery) were studied using Pearson’s correlation coefficients. Coefficients <0.29, 
0.30-0.49 and >0.49 are interpreted as small, moderate and large, respectively (23). 
 
Two three-step hierarchical multiple regression analyses were computed to determine 
predictors of physical and mental health (component summaries PCS and MCS of the 
SF-36; study II). Variables considered to influence patients’ physical and mental health 
were entered into the model. In the first step age, gender and FAP in the family was 
included; in the second step age at last colorectal surgery and type of performed surgery 
(IRA, IPAA or ileostomy) were forced into the model; and in the third step number of 
symptoms and troublesomeness were forced into the model.  
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Study III 
Descriptive statistics (means and standard deviations) were computed for components 
of the IPQ-R and dimensions of the SF-36. Differences in subgroups (gender, family 
history of FAP and adherence to endoscopic surveillance) were tested by independent t-
tests. 
 
To investigate internal consistency reliability Cronbach's alpha coefficients were 
calculated for each IPQ-R component in study III (Timeline-chronic, α=0.83; Timeline-
cyclical, α=0.67; Consequences, α=0.84; Personal control, α=0.67; Treatment control, 
α=0.61; Emotional representation, α=0.89; Illness coherence, α=0.87). Cronbach’s α in 
the vicinity of 0.70 or higher is considered reliable, which is why the Treatment control 
component was considered unreliable and therefore deleted from all analyses. Although 
the Cronbach’s α of the component Personal control did not reach 0.70 it was 
considered acceptable, and therefore included in the analyses. 
 
In study III five three-step hierarchical regression analyses were performed to 
determine predictors of HRQL. Results from the first study showed that living with 
FAP was associated with several patient concerns. Scrutinizing the identified concerns 
in relation to the scales of the SF-36, patient concerns were related to five of the scales: 
Bodily pain, General health, Vitality, Social Function and Mental health. These scales 
were therefore entered into the regression analyses as dependent variables. In the first 
step age, gender and FAP in the family were included; in the second step time since last 
colorectal surgery and number of symptoms were forced into the model; and in the 
third step six components of the IPQ-R (Timeline-chronic, Timeline-cyclical, 
Consequences, Personal control, Illness coherence and Emotional representation) were 
additionally included in the model.  
 
Study IV 
The answers to the 25 QPP items, measuring quality of care, were dichotomized into 
two categories: agree (“strongly agree” and “agree”) and disagree (“disagree” and 
“strongly disagree”). The proportion of patients who agreed is presented and 
differences in categorical variables were tested by χ2 tests. 
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Cronbach’s alpha coefficients were calculated to estimate internal consistency 
(Identity-oriented approach, α=0.94; Medical-technical competence, α=0.75 and Socio-
cultural atmosphere, α=0.70).  
 
Logistic regression analyses were performed to examine predictors of quality of care. 
The three dimensions of the QPP included in study IV were dichotomized into low 
quality of care=0 (1st, 2nd and 3rd quartile) and high quality of care=1(4th quartile) and 
entered as dependent variables. The independent variables were sex (0=women, 
1=men), age, time since last colorectal surgery, FAP in the family (0=no, 1=yes), 
organization of care (0=non-specialized care, 1=specialized care) and number of 
symptoms.  
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7 ETHICAL CONSIDERATIONS 
Since World War II, several ethical guidelines have been formulated. One of the most 
pre-eminent documents addressing research ethics is the Declaration of Helsinki (67). 
The Declaration of Helsinki was adopted by The World Medical Association. The 
ethical principles were developed for medical research involving human subjects in the 
1960s and later revised several times, most recently in 2008. The principles bind the 
researchers to protect life, health, dignity, integrity, right to self-determination, privacy 
and confidentiality (WHO). In addition, most disciplines have formulated their own 
code of ethics. For nurses, The American Nurses Association (ANA) nine ethical 
principles for the guidance of nursing research (68). Mutual for the Declaration of 
Helsinki and ICN is the principle of beneficence – do no harm – including physical, 
psychological and economic harm (67, 68). This thesis was preceded by a research 
protocol that included information about study design. Formal ethical approval of the 
four studies of this thesis was granted by the Regional Ethic Review Board in 
Stockholm (registration number: 04-241/3, 2007/1400-31/2). A letter was sent to 
potential participants with information about the studies. The letter also informed about 
the benefits of the study (e.g., that we would learn more about surgically treated 
individuals with FAP) in order to organize care and support based on the findings. It 
has been suggested that in contrast to medical research, qualitative research may be 
more vulnerable to ethical issues that may arise from problems uncovered in the 
research process (69). Therefore, participants in study I were informed about the 
possibility of negative psychological effects created by being involved in the focus 
group interviews and were therefore encouraged to call the researcher if they needed 
future support.  
 
The second principle, dignity, includes the right to self-determination and the right of 
full disclosure (67, 68). To help individuals make informed decisions about 
participation all participants received a letter with information about the study, 
including a telephone number to the researcher if questions were raised. To prevent 
coercion the information letter emphasized that participation was voluntary and that 
participants could withdraw without consequences at any time during the study. To 
minimize the pressure of participation no reminder was sent to the participants in study 
I. This tactic was important because the participants in study I were recruited from the 
outpatient clinic affiliated to the Swedish Polyposis Registry where two of the 
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researchers worked. For studies II-IV, the individuals who subsequently agreed to 
participate were asked to complete the set of questionnaires and to return them in an 
enclosed pre-paid envelop. Patients who did not return the questionnaire were sent a 
reminder after three weeks. The third principle, justice, refers to participants’ right of 
fair treatment and privacy (67, 68). In the information letter (Study I-IV) it was 
emphasized that non-participation or withdrawal of consent would not affect a patient’s 
care or treatment. To provide access to research personnel at any time during the study 
the cell-phone number to one of the researchers (KF) was included in the information 
letter. Anonymity is impossible to guarantee in qualitative research; however, 
confidentiality was implemented by omitting the name of participants during the 
transcription of the interviews. Each participant was given a number for identification. 
Anonymity for participants in studies II-IV was also not possible because of the need 
for additional clinical data. To ensure confidentiality all questionnaires were provided 
with a number. Each patient’s number code key was locked up and separated from the 
completed questionnaires. No names or personal numbers were entered into the data 
file. Furthermore, the data received from the studies are presented such that 
confidentiality is ensured. Interview data provided from study I are presented with 
quotes, but without names. For study I participants signed an informed consent before 
contact by the researcher (LW). For studies II-IV, no sign informed consent form was 
sent to potential participants. Instead, the completed questionnaires that were returned 
to the research group were taken as the participants’ consent to participate.  
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8 RESULTS 
 
8.1 CONCERNS IN LIFE AND MANAGING LIFE 
The three focus group interviews were analyzed both within and across groups. 
Agreement on aspects of living with FAP was found between the three focus groups, 
whereas family planning and issues on employment were more frequently discussed in 
the youngest focus group. A positive interaction was found in all three focus groups but 
was especially salient in the two youngest focus groups, where the participants seemed 
to value the opportunity to discuss their personal experiences with each other. The 
results from the focus group interviews were revealed in two categories (concerns in 
life and managing life). Both categories were found to be associated with the heredity 
and lifelong nature of FAP, as well as to life after prophylactic colorectal surgery. In 
addition, managing life was related to acceptance of having FAP.  
 
8.1.1 Concerns in life 
Living with a hereditary disease 
One aspect discussed frequently was the risk of FAP with respect to the participants’ 
children. The discussion included concerns about the risk of children inheriting FAP 
and, despite this risk, a wish for having children. One young man said “...to refrain 
from a child with FAP would feel like refraining from my own life-- and my life is pretty 
good...” Furthermore, concerns for the health of close family members were also 
discussed, as one women said, “… there was a risk that he (sibling) had developed 
cancer /-/ I live with this all the time...”. Family members’ deteriorating health was also 
a reminder of one’s own risk for poorer health. One woman said, “... I think about what 
is going to happen with my body in the future, especially since I have seen my brother. I 
am going to have an ileostomy. It’s certain and just a matter of time…”. Furthermore, 
being brought up in a family with FAP could result in a negative view of FAP. One 
woman put it in the following words: “...my mother was the first survivor of the disease 
in the family; 14 relatives had died. I have my mom’s bitterness against the disease. 
She had problems living with it…” 
 
Living with a lifelong disease 
Concerns were related to the fact that FAP is a relatively rare disease, resulting in a lack 
of knowledge about the illness not only among friends but also among health care 
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professionals. Most participants told friends that they have FAP, but found it difficult to 
share deeper emotions about it because of the fear of scaring away friends. The most 
frequently discussed issue, was the concern related to health care professionals’ lack of 
knowledge about FAP. One older woman with a long experience of living with FAP 
expressed the following: “...they (health care professionals) don’t understand what this 
disease is: that’s my opinion /-/ they make me really annoyed. They don’t understand 
anything /-/ no I don’t think that they understand anything”. Participants also expressed 
that health care providers were indifferent to listen to what they had to say about their 
illness or to learn more about the illness, which resulted in feelings of insecurity and 
neglect. 
 
Life after prophylactic surgery 
Prophylactic colorectal surgery was discussed as a ‘turning point’, as one young man 
expressed it. “... it’s probably the worst thing ever /-/ when the doctor did the ward 
round /-/ he took a chair and closed the door /-/ and he said, ‘your life is going to 
change from now on’. I didn’t know anything about the disease then...” Some patients 
described how they went from a healthy to an unhealthy state (e.g., abdominal 
symptoms, decreased bowel function, restrictions in food intake and reduced social life 
as a result of surgery). One woman expressed how she felt when visiting public toilets: 
“... I panic /--/ it (the intestine) makes noises and so /--/ you can’t do anything about it-- 
it’s out of control…” In addition, unmet needs (such as psychological support at time of 
surgery) were discussed. One participant noted, “...when the surgeons were done and 
satisfied with the result, I felt like a victim...” Worries about the risk of having to 
undergo additional surgery in the future were also frequently discussed, which was 
related to an unwillingness to undergo surgery, as well as the risk of not knowing how 
it would affect bowel function. Recurrent hospital visits had an influence on the 
patients, constantly reminding them of their disease: as one patient put it, “I only feel ill 
once a year and that is when I have the doctor’s appointment or the endoscopic 
examination. This is the only time I have FAP-- in between I don’t...”. Moreover, the 
regular screening procedures, especially gastroscopy, including the laxative 
preparation, were described as very unpleasant.  
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8.1.2 Managing life 
Dealing with a hereditary disease 
Being raised in a family with FAP was positive for some participants. One woman put 
it this way, “…my father has a stoma so we have talked about it. It (FAP) has always 
been in the family /-/ it has been quite easy to talk about...” Having hopes for better 
treatment alternatives for their children in the future were expressed by statements such 
as, ‘treatment for FAP will progress’ and ‘in the future our children may just take a 
tablet of medicine instead of having to undergo prophylactic colorectal surgery’. 
 
Dealing with a lifelong disease 
Thinking positive and finding positive things in life were ways of dealing with 
concerns associated with the lifelong disease. One patient said, “... I usually think that I 
could have a disease worse than this...” Another patient remarked, “...yes, exactly I 
could have been dead...” Finding ways to deal with the endoscopic examinations to 
minimize their worries varied considerably and were highly individual. For instance, 
some patients wanted to follow the examination on the screen, whereas others avoided 
looking at the screen. Some patients requested sedatives before undergoing 
gastroscopy, whereas others did not.  
 
Dealing with food and toilet habits 
Many patients expressed how they tried to avoid problems and pain from the intestine 
by such methods as ‘trial and error’ or by defying food restrictions and hoping for the 
best. The participants took and gave advice. The participants also seemed to take the 
opportunity to share their experiences with others with the same problems. The 
participants frequently discussed and shared ways of planning social activities. As one 
woman explained, some needed extensive planning, “...I want to know exactly where 
the toilet is /-/ before I go into the cinema, I usually go two or three times to the toilet 
just to be sure that I can sit down during the whole movie”. Other patients reported 
making minor adjustments before joining social activities. Different ways of dealing 
with FAP at work were expressed: for instance, one young woman said, “... I speak 
freely about it /-/ I have to have someone to cover up for me if I need to go to the 
toilet…” Another woman said, “...I never told anyone about it /-/ every time I had an 
appointment for an examination or if I felt sick I took a vacation day...” 
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Learnt to live with 
Most of the participants in the focus groups expressed acceptance of living with FAP. 
A majority of the participants felt they lived a normal life despite the illness. One 
participant remarked, “... I live a normal life basically /-/ except for the examination I 
have to go through...” Acceptance of having to undergo endoscopic examinations and 
of having to be off work during the days around the examination was also expressed. 
One participant with ileostomy felt independent because he no longer had to be close to 
a toilet. 
 
8.2 ABDOMINAL SYMPTOMS (STUDY II) 
Totally, 190 patients (91%) reported at least 1 of 21 possible symptoms, measured with 
the Abdominal Symptoms Questionnaire (ASQ; table 1); a mean of 7 (SD 4.61; range 
1-18) symptoms was reported. Women reported a statistically significant higher 
number of abdominal symptoms than men (women: mean=8, SD=4.89, range 0-18; 
men: mean=5, SD=4.49, range 0-18), whereas no differences were found in perceived 
troublesomeness. Abdominal symptoms by type of colorectal surgery are presented in 
Table 4.  
Table 4. Presence of abdominal symptoms the last three month, by type of surgery, measured 
with the Abdominal Symptom Questionnaire (ASQ)  
 IRA  
(n=71) 
IPAA  
(n=82) 
Ileostomy 
(n=39) 
 n % n % n % 
Diarrhea 50 72 59 73 19 49 
Borborygmi 43 62 62 77 16 41 
Nighttime urge of defecation 32 46 60 74 25 64 
Abdominal distension 32 46 49 60 16 41 
Abdominal discomfort or pain relieved by defecation 36 52 36 44   9 23 
Troublesome passage of gas 31 45 24 30 12 51 
Feeling of incomplete defecation 22 32 38 47   3   8 
Feeling of fullness after meals 25 37 25 31 14 36 
Nausea 18 26 30 37 12 31 
Retrosternal pain 23 34 23 28 13 33 
Belching 20 30 25 31 12 31 
Heartburn 22 32 20 25 14 36 
Early satiety 20 29 29 36   7 18 
Abdominal discomfort or pain on defecation 19 28 22 27 10 26 
Reflux episodes 14 21 17 21 13 33 
Loss of appetite 12 18 18 22   5 13 
Constipation   9 13 10 12   8 21 
Altering diarrhea and constipation   9 13   7   9   3   8 
Vomiting   6   9   8 10   4 10 
Loss of weight   6   9   7   9   2   5 
Dysphagia   4   6   7   9   -   - 
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All 21 possible symptoms were reported by participants with IRA, IPAA and 
ileostomy, except for dysphagia, which was not reported by participants with 
ileostomy. No statistically significant differences in perceived troublesomeness or in 
mean number of symptoms were reported by type of prophylactic surgery.  
 
To evaluate health status two three step hierarchical analyses were computed. The first 
hierarchical regression analysis was computed with the physical summary component 
of the SF-36 (PCS) as dependent variable. In the first step sex, age and FAP in the 
family were entered into the model. In step 2 time since last colorectal surgery and type 
of surgery (IRA, IPAA or Ileostomy) were forced into the model. Finally, in step 3 the 
number of symptoms and troublesomeness were forced into the model. In the final 
model, when the variances of the other independent variables were held constant, only 
age (β standardized= -0.332) and number of abdominal symptoms (β standardized= -
0.465) were significant contributors to the model (R2 change=0.217, R2 adjusted=0.332, 
F=11.043).The second hierarchical regression analysis was computed with mental 
summary component of the SF-36 (MCS) as the dependent variable. In the first step 
sex, age and FAP in the family were entered into the model. In step 2 time since last 
colorectal surgery and type of surgery (IRA, IPAA or Ileostomy) were forced into the 
model. Finally, in step 3 the number of symptoms and troublesomeness were forced 
into the model. The final model showed that, when the variances of the other 
independent variables were held constant, only age (β standardized= 0,215) and number 
of abdominal symptoms (β standardized= -0.459) were significant contributors to the 
model (R2 change=0.226, R2 adjusted=0.329, F=10.923). The final models accounted 
for more than 30% of the variance of physical health and 30% of the variance of mental 
health. 
 
8.3 ILLNESS PERCEPTION (STUDY III) 
Overall, the results for illness perception show that the participants view FAP as a 
chronic illness (timeline) and possible to control to some extent (personal control). 
Moreover, negative impact (consequences) on life and emotional distress (emotional 
representation) that are due to FAP are viewed to a limited extent. High scores on the 
component illness coherence indicate that the participants have a good understanding of 
their illness (Table 5). FAP-specific symptoms were reported to be related to FAP to a 
high extent, indicating a strong illness identity. Furthermore, a majority of the 
participants reported heritage as the most important reason for having the illness. The 
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subgroup analysis revealed that women perceived FAP as having a more negative 
impact on their life (consequences) and had a stronger negative emotional response 
(emotional representation) to the illness than men (men mean=15.31, SD=5.42, women 
mean=17.97, SD=5.53, p<0.01; men mean=14.32, SD=5.97; women mean=16.97, 
SD=5.31, p<0.01). Another finding was that participants with a history of FAP in the 
family had a greater understanding (illness coherence) of the illness and perceived a 
less negative impact (consequences) on life compared with patients without a history of 
FAP in the family (FAP in the family mean=20.62, SD=4.03, without FAP in the 
family mean=17.75, SD=4.16, p<0.001; FAP in the family mean=16.20, SD=5.54, 
without FAP in the family mean=19.28, SD=5.38, p<0.01). Individuals who were 
adherent to endoscopic surveillance perceived the illness to be chronic (timeline-
chronic) to a higher extent and perceived more negative emotions (emotional 
representation) to the illness than participants’ who were non-adherent to endoscopic 
surveillance (adherent mean=27.29, SD=3.32, non-adherent mean=25.52, SD=4.92, 
p<0.05; adherent mean=16.14, SD=5.67, non-adherent mean=12.90, SD=5.39, p<0.01).  
 
Table 5. Illness perception questionnaire, measured with 
the Revised Illness Perception Questionnaire (IPQ-R)  
 mean SD 
Timeline - chronicf 27.04 3.62 
Timeline - cyclicalg 10.52 3.37 
Consequencesh 16.79 5.63 
Personal controli 16.69 4.48 
Illness coherencej 20.07 4.20 
Emotional representationk 15.69 5.73 
 
Meaning of higher score: 
fTimeline (chronic) - stronger beliefs that the condition is lasting rather than acute in 
nature; possible score 6-3 
gTimeline (cyclical)- stronger beliefs that the condition is cyclical rather than acute in 
nature; possible score 4-20 
hConsequences - stronger beliefs that the illness will have a negative impact on the 
person’s life; possible score 6-30 
iPersonal control- positive beliefs about personal control; possible score 6-30 
jIllness coherence – a greater perceived personal understanding of the illness; possible 
score 5-25 
kEmotional representation - stronger negative emotional responses to the illness; 
possible core 6-30 
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8.4 HEALTH-RELATED QUALIT Y OF LIFE (STUDY III) 
HRQL, measured by the eight subscales of the SF-36, showed that women perceived a 
worse HRQL than men in five of the eight subscales (Physical function, Role physical, 
Bodily pain, General health and Vitality). To investigate predictors of HRQL five three 
step hierarchical analyses were computed with the SF-36 subscales (Bodily Pain, 
General health, Vitality, Social function and Mental health) as dependent variables 
(Table 6). When the effect of gender, age and FAP in the family was already accounted 
for (first step), the number of abdominal symptoms (second step) had a statistically 
significant effect on all subscales. In the third step the addition of the components of 
the IPQ-R contributed to the models in all subscales except for Mental health. The final 
models accounted for 33 to 58% of the variance in HRQL. 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6. Hierarchical multiple regression analyses with the subscores of the SF-36 as dependent variables (n=190) 
 Bodily pain  
 
General health  Vitality  Social function Mental health 
 R2  
change 
R2 
adjusted 
R2  
change 
R2  
adjusted 
R2  
change 
R2  
adjusted 
R2  
change 
R2 
adjusted 
R2  
change 
R2  
adjusted 
Step           
1c 0.075** 0.060 0.061** 0.046 0.065** 0.050 0.052* 0.037 0.062** 0.047 
2d 0.215*** 0.271 0.362*** 0.408 0.343*** 0.391 0.297*** 0.331 0.254*** 0.298 
3e 0.074 0.324 0.182*** 0.581 0.074** 0.450 0.109*** 0.425 0.111*** 0.392 
*p<0.05, **p<0.01, p<0.001, The sub scores of the SF-36 range from 0 to 100 with higher scores indicating better health status 
CPredictors: gender, age, FAP in the family; dPredictors: time since last surgery, number of symptoms ePredictors: IPQ-R  
components: timeline-chronic, timeline-cyclical, consequences, personal control, treatment control, illness coherence, emotional 
representation 
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8.5 QUALITY OF CARE (STUDY IV) 
Overall quality of care was rated high for all three dimensions (Identity-oriented 
approach: median=4, IQR 2-4; Medical-technical competence: median=4, IQR 3-4; 
Socio-cultural atmosphere: median=4, IQR 2-4). Individuals receiving specialized care 
reported statistically significant higher agreement, reflecting better care, on 18 of the 25 
statements included in the three dimensions of the QPP. Accessibility was reported to 
be easy or very easy to a higher extent by individuals receiving specialized care 
compared with individuals receiving non-specialized care (specialized care 60% vs. 
non-specialized care 40%, p<0.01). Furthermore, in comparison with patients receiving 
non-specialized care, a lower proportion of individuals receiving specialized care 
hesitated to revisit the clinic (specialized care 4% vs. non-specialized care 26%, 
p<0.001).  
 
Logistic regression analyses were carried out with the three dimensions (Identity-
oriented approach, Medical-technical competence and Socio-cultural atmosphere) of 
the QPP serving as dependent variables. The models showed that individuals receiving 
specialized care and those with a lower number of abdominal symptoms were more 
likely to report good quality of care than individuals receiving non-specialized care and 
those with a higher number of abdominal symptoms. Odds ratios (ORs; the probability 
of an event) for organization of care ranged from 14.332 to 8.049 while ORs for 
number of symptoms ranged from 0.871 to 0.898 (Table 7).   
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Table 7. Logistic regression analyses with the 3 dimensions in the Quality of Care from the Patients Perspective (QPP) 
as dependant variablesa (n=122-205) 
Dimensions  Sexb Age History of 
FAP  
in the 
familyc 
Time since 
last  
colorectal 
surgery 
Organization  
of cared 
Number of  
symptoms 
Identity-
oriented 
approach 
OR 2.424 1.013 1.875 0.995 14.332** 0.871* 
99% C.I 0.880-6.674 0.973-1.055 0.547-6.433 0.943-1.051 2.536-81.005 0.782-0.971 
        
Medical-
technical 
competence 
OR 1.346 1.008 0.962 1.008 8.049** 0.898* 
99% C.I 0.547-3.308 0.974-1.043 0.313-2.955 0.959-1.060 2.345-27.628 0.812-0.993 
        
Socio-
cultural 
atmosphere 
OR 1.044 0.999 1.484 0.989 9.764** 0.844* 
99% C.I 0.366-2.976 0.959-1.040 0.437-5.040 0.936-1.045 1.754-54.361 0.753-0.947 
alow quality of care=0, high quality of care=1, bmen=0, women=1; cFAP in the family yes=0, no=1; dspecialized care=0, non-
specialized care=1  
*p<0.01, **p<0.001 
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9 DISCUSSION 
9.1 GENERAL DISCUSSION OF THE FINDINGS 
The results of the four studies included in this thesis reveal that surgically treated 
individuals with FAP perceive their lives to be influenced by having FAP in several 
ways. Unspecific abdominal symptoms have not previously been investigated to the 
same extent as they have in this thesis. A majority of the participant’s perceived 
abdominal symptoms and in contrast to other studies (11) that was independent on 
type of surgery. Interestingly, when calculating t-tests to compare means of SF-36 
scales between the individuals with FAP and published norm data for the general 
Swedish population (61) individuals with FAP appear to have a diminished physical 
health (Role function, Bodily pain, General health and Social function; data not 
shown). This corroborates to the results showing a high symptom burden and need of 
health care in this group found in study I and II However, the norm values for the 
Swedish population are gathered more than ten years ago why this should be 
interpreted with caution. An important finding of this thesis is the influence of 
abdominal symptoms on HRQL. HRQL worsened with increasing number of 
abdominal symptoms. The focus group interviews gave insight into how social life 
could be influenced by a person’s symptom (e.g., visiting toilets outside the home 
was associated with a feeling of lack of control because of the unpredictable passage 
of gas). Further, the qualitative data revealed the impact on life caused by symptom 
clusters (10), one individual pointed out that it was sometimes difficult to figure out 
what was wrong. She called days like that “belly days”, and that was when her 
stomach was upset. The results indicate that an effective management of symptoms 
would improve HRQL, in line with a study of individuals with ulcerative colitis who 
receive similar treatment to patients with FAP (70).  
 
The prophylactic surgery was perceived as a turning point from which individuals went 
from a healthy to an unhealthy state and felt a lack of control. In contrast to other 
studies (47, 55) that was independent of type of surgery and age at time of surgery. 
Despite the fact that the prophylactic surgery may be seen as traumatic and the reason 
for a wide range of abdominal symptoms, the illness perception of individuals, revealed 
from both quantitative and qualitative data, in this thesis indicates that they, in general, 
adjust well to the illness. However, the illness perception of individuals without FAP in 
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the family showed that they had a poorer understanding of the illness and a perception 
of more negative consequences of the illness compared to individuals with FAP in the 
family. Although, the results from the focus group interviews revealed a more complex 
picture of the effect of the illness on individuals who have family members with FAP. 
The results showed that having family members with FAP was associated with 
concerns for the health of family members. Further, when family members had 
additional operations or their illness deteriorated, increasing worries about their own 
health were perceived. The use of a wide range of self-care strategies to minimize the 
effect of the illness on life, found in the focus group interviews, may cause the health 
care providers to overlook symptoms and concerns of their patients. Individuals with 
chronic illnesses may not always discuss with health care professionals problems about 
their everyday life, nor what kinds of self-care actions they use (6). Individuals who are 
newly diagnosed may need extra attention in that self-care decisions can be 
overwhelming in the initial phase of an illness, but over time demand less attention (4). 
 
This thesis revealed some differences between men and women. Women reported more 
symptoms than men. With regard to illness perception women had more negative 
emotions and perceived more negative consequences to the illness than men. However, 
surgically treated women with FAP may not differ to women from the general 
population since women report abdominal symptoms (71) and health complaints to a 
higher extent than men (72). Non-adherence was found to associate with lower 
emotional responses to the illness and a perception of FAP as less chronic. Such results, 
however, are in contrast to a study showing that higher emotional responses and low 
personal control were associated with non-adherence in individuals with hypertension 
(73). The differences in results are hard to explain since the reason for non-adherence in 
the present thesis was not explored. However, it is well-known that worry and anxiety 
are motivators of illness behavior (74). One possible contributing reason for non-
adherence may be related to organization of care. Individuals perceiving high quality of 
care were more likely to receive specialized care and present with a lower number of 
abdominal symptoms. Specialized care is provided with the aim of gaining and 
maintaining positive relations with individuals, important for building partnerships (75) 
and for an individual’s participation (76, 77) and adherence to professional 
recommendations (78). Knowledge of the organizational structures and priorities of the 
clinics outside the Swedish Polyposis Registry is gained from medical records and may 
therefore not be comprehensive. Nonetheless, according to the medical records, it is 
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common that several physicians are involved in the care of an individual, and that in 
general nursing care is lacking. It also seems that although several individuals with 
FAP are affiliated to the same hospital/clinic, they often receive care from different 
physicians. This situation may result in a lack of combined knowledge, which is 
especially important when caring for individuals with such a rare disease. 
 
The results of the studies in this thesis indicate that surgically treated individuals with 
FAP would benefit from a care that focuses on the support of the individual’s self-care 
(6). To improve HRQL the management of abdominal symptoms is vital, as negative 
consequences on life perceived by the individual. As the discipline of nursing is based 
on a holistic approach, nurses are suggested to be especially important when caring for 
chronically ill individuals. It is important that interventions fit in with an individual’s 
day-to-day life, and an approach not limited to medical characteristics (e.g., type of 
surgery) (6). In the context of FAP having diverse interaction approaches (e.g., support 
groups, follow-up programs) (6), patient education (individual or group), education for 
family members and interventions over the internet and phone would be beneficial (6, 
79). However, one obstacle previously discussed which also is transmittable to health 
care in the Swedish context, is the difficulty of getting reimbursement for non-visiting 
methods of interaction (79). In the Stockholm county council reimbursement is 
(almost) only provided for face-to-face physician-patient interactions that includes 
some form of medical treatment. This restriction is highly problematic when caring 
(e.g., supporting self-care) for individuals with chronic diseases, such as FAP. 
 
 
9.2 METHODOLOGICAL CONSIDERATIONS  
9.2.1 study design 
A major strength of the thesis is the use of both a qualitative and quantitative approach, 
which allowed for insight into how individuals with FAP perceive life after surgery, 
from different angles. However, the cross-sectional design of the studies precludes the 
assessment of causal relationships (80). Furthermore, because no control group was 
used, the information cannot be considered conclusive.  
 
9.2.2 Focus group interviews  
The rich data source of the focus group interviews indicates the appropriateness of the 
method of data collection. Classifying the participants into groups based on age seemed 
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to facilitate the discussion since some of the areas (such as family planning and career 
issues) were more frequently discussed in the youngest group. Participants discussed 
areas not included in the interview guide, such as individual’s relationship to health 
care professionals and ways of managing everyday life problems. The easiness of 
discussing sensitive topics in focus groups has been questioned (81). Concerns about 
developing cancer in the future were not mentioned in the present study. One possible 
explanation could be that the participants perceived the risk for future cancer to be too 
sensitive to bring up in a group session, which is one reason why individual interviews 
may have been a more appropriate method. Still, it is also possible that individuals do 
not view FAP as a cancer disease since the majority (79%) of the participants in the 
focus group interviews never had cancer.  
 
In qualitative studies methodological considerations refer to trustworthiness defined by 
terms such as credibility, dependability and transferability (66). Credibility pertains to 
the focus of the research and the appropriateness of data collection, the amount of data 
gathered and analysis of the data, as well as context selection (66). In the current study 
the participants represented all ages, both men and women participated and they had 
experience of living with symptoms as a result of different surgical methods, which 
contributes to a rich variation of the phenomena under study (81). In comparison with 
other qualitative methods, interaction is a unique part of the focus group method. It has 
been argued that focus group interviews may have an intervention effect rather than 
being solely a research method. However, the loquaciousness of the focus group 
participants during the interviews was a result of the positive attitudes toward meeting 
other persons in the same situation. This provided rich data from all three focus groups 
and greatly helped in answering the research questions. The literature usually 
recommends 4-8 participants in a focus group (81). The low number (n=2) of 
participants in the youngest focus group was due to the last minute withdrawal of 
participants. The decision to carry on with the interview was made because the two 
participants had invested their time in coming. Since the data was considered sufficient 
and the content from all three focus groups were analyzed together, no further attempts 
to gather young persons with FAP to an additional focus group were made. Another 
critical issue for achieving credibility is the quality of the data analysis (66). The first 
author in the study (KF), who conducted the early stage analysis of the data, has 
extensive experience in clinical practise of patients with FAP. Henceforth, during the 
analysis process, codes, subcategories and categories were discussed among the co-
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authors (LW, CP) until a final agreement was reached (65, 66). Whether pre-
understanding is an advantage or disadvantage in qualitative research is not clear but 
some consider pre-understanding to be an obstacle for an objective analysis (82). Since 
the main researcher who analyzed the interviews had extensive knowledge in the 
participating patients’ illness, her pre-understanding and its possible influence on the 
analysis process were continuously discussed among the co-authors. One co-author 
(CP) involved in the analysis process came from outside the research group and had no 
experience of FAP. Furthermore, one of the co-researchers (LW) had many years of 
research experience from the perspective of patients with cancer within the field of 
nursing sciences but had no previous knowledge in FAP. Dependability deals with the 
degree to which data change during data collection or during the analysis process (66). 
To prevent alterations in data collection procedures and preserve data integrity the same 
moderator (LW), collected the data from all three focus groups. In addition, the use of 
an interview guide prevents inconsistencies when questioning participants (66). 
Transferability refers to what extent the findings can be transferred to other settings 
(66). In what way the results of the focus group interviews can be generalized to other 
settings is uncertain. The findings reflect the situation of patients at a specialized clinic 
in Sweden and may not be representative of the FAP population as a whole. This must 
be seen as a limitation of the study. Another point to consider is that there were more 
women than men participating and the mean age of the participants was relatively high. 
Nevertheless, the findings may partly be transferable to other settings in that the study 
participants, in comparison with the Swedish FAP population, did not differ on several 
characteristics (e.g., time since diagnose, type of surgery, desmoid tumours and FAP-
related cancer).  
 
9.2.3 Validity and reliability 
Validity refers to what extent a measure reflects the latent construct it is intended to 
measure and to which extent the results can be reproduced (80). A major strength of 
studies with a quantitative approach in this thesis is the unique representative cohort of 
surgically treated individuals with FAP. The sample was recruited from the national 
Swedish Polyposis Registry, which is considered to cover nearly the entire FAP 
population in Sweden. The response rate was 76%; no differences in demographic and 
clinical characteristics between responders and non-responders were found, why the 
risk of selection bias was limited. Because of the high response rate regression analyses 
that allow controlling for confounders (factors that associate with outcome) could be 
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used (Study II-IV). To increase the interpretation of the results major efforts were made 
to detect and complete missing data. Given the high response rate and the sample 
recruiting mentioned above, the generalizability to the Swedish FAP population who 
have undergone prophylactic colorectal surgery must be considered high. 
 
The use of a questionnaire not previously used to investigate abdominal symptoms in 
this population (i.e. the ASQ) could be a threat to the validity of the study. The results 
of study II emphasize the appropriateness of using the ASQ in that the abdominal 
symptoms included in the questionnaire were frequently reported by the participants, 
indicating their importance in this context (23).  
 
Reliability refers to whether an instrument measures the concept in a consistent manner 
(80). The questionnaire used to assess illness perception has been employed in 
individuals with different disorders; however, its use in a genetic disease context is 
limited. The reliability of the component Treatment control was not acceptable and 
therefore deleted from the analyses (23). That may be a result of the phrasing of the 
items, it has been suggested that questions about treatment effectiveness in controlling, 
improving and curing an inherited disease may seem irrelevant (83). This was further 
emphasized by a study of two nurses who tested the IPQ-R in individuals with two 
chronic bowel diseases (Ulcerative Colitis and Crohn’s disease) using a think-aloud 
strategy (84). The results of that study confirm the problem of measuring treatment 
control by asking about treatment effectiveness in curing a chronic disease.  
  
Measuring HRQL in surgically treated individuals with FAP with a generic rather than 
disease-specific questionnaire may not capture all aspects of HRQL. However, it has 
been suggested that measuring quality of life with both a generic and a disease-specific 
questionnaire are relevant (85). The results from this thesis indicate the relevance of 
including aspects that have a negative impact on life in individuals with FAP. However, 
no such questionnaire exists today. For future studies, a more individualized approach 
in which individuals define what quality of life means to them in relation to goals and 
expectations may be beneficial.  
 
One limitation of study IV in its measure of quality of care is item selection, i.e. 25 
items of 47 from three of four dimensions were included in the study. The item 
selection refers to the aspects of efficiency. To reduce the amount of time for 
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individuals to answer the questions included in the questionnaire package the most 
relevant items were selected. Measuring quality of care is a well-known 
methodological difficulty in that patients in general report high levels of perceived 
quality of care independent of care received and questionnaire used (86, 87), resulting 
in skewed data and ceiling effects. Such effects were also found in study IV. Well-
validated questionnaires measuring quality of care or satisfaction in the outpatient 
context (and in a broader sense than the physician-patient dyad) are difficult to find. 
One advantage of the QPP is the items regarding quality of care delivered by nurses, 
which must be considered important in the evaluation of quality of care because they 
are highly involved in the care of individuals. To avoid the risk of a type 1 error (false 
positive result) because of the large number of analyses carried out in study IV the 
statistical significance level used was lowered (80).  
 
9.3 IMPLICATIONS FOR CARE 
In the context of FAP, support in self-care should address patient concerns in several 
areas, including the management of abdominal symptoms in accordance with the 
individuals’ own strategies in managing those concerns. Individuals may benefit from 
pre- and post-surgery support. Further, the laxative procedure and concerns regarding 
endoscopic examinations should be addressed and interventions should be discussed 
with the individual. However, when supporting self-care, the most important factor to 
remember is that the individuals are the expert regarding their unique needs. Care for 
surgically treated individuals with FAP should be provided by a team specialized in 
FAP including genetic counselors, physicians, surgeons, welfare officers and dieticians, 
preferably coordinated by a nurse. The coordinating nurse should be specialized in the 
care of chronically ill individuals, including support of self-care by building partnership 
with each individual, promoting positive thoughts about the individual’s self, 
facilitating the individuals control over their life situation, building on the individuals’ 
capabilities and establishing mutual health-directed goals. Support self-care implies 
addressing the needs of an individual: simply asking individuals about what 
consequences the illness will have on their life may be the best way to individualize 
interventions. Because of the rareness of FAP, care should be centralized to a few 
university hospitals in the country.  
 
The Swedish Polyposis Registry brings patients and relatives together for special 
education days once a year with the aim of improving FAP knowledge and 
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disseminating the latest guidelines and research in the field. Although participants are 
from throughout the country, not all individuals have the possibility to go to Stockholm 
to attend this education. More innovative ways of disseminating guidelines and 
research, as well as bringing individuals together may be beneficial. Using the Internet 
is one means of narrowing the distance between patients. A chat group for patients with 
FAP has been developed by a patient support group and patients have created a FAP 
group on Facebook. Unfortunately, at present, the SPR does not provide a website that 
allows networking and ‘chat groups’. In addition to other interactive websites, it would 
be beneficial if the Swedish Polyposis Registry could provide a platform for 
interactions because the website includes updated information about FAP and treatment 
guidelines, as well as information about the clinic affiliated to the Swedish Polyposis 
Registry.    
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10 CONCLUSION 
The findings reveal that life of surgically treated individuals with FAP is influenced in 
several ways including issues about hereditary, the life-long nature of the illness and 
abdominal symptoms. A high number of abdominal symptoms was reported; this had a 
substantial impact on HRQL and self-reported quality of care. Patients undergoing 
follow-up at a specialized clinic rated quality of care better than those cared for at other 
clinics. Despite concerns related to the illness, individuals with FAP appear to get along 
with life quite well.  
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11 FUTURE PERSPECTIVE 
Future research could build on the results from this thesis by investigating the impact of 
symptom clusters, the relationships to family and friends and economic concerns, all of 
which would help us gain valuable information about FAP and its influence on the 
patient’s daily life. Moreover, future research is recommended to study the effects of 
endoscopic surveillance on the individual’s life, particularly the impact that laxative 
procedures and the examination process has on the individual’s well-being. Future 
research pertaining to quality of care is recommended by investigating the impact of 
inpatient care, with particular focus on days of inpatient care and reasons for inpatient 
care. Knowledge about anticipatory factors of inpatient care is important when 
supporting self-care in order to prevent inpatient care and reduce the impact on life.  
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12 SAMMANFATTNING PÅ SVENSKA 
Familjär adenomatös polypos (FAP) är en relativt ovanlig, ärftlig sjukdom som medför 
en mycket hög risk för cancer. I preventivt syfte genomgår alla personer med FAP 
kolektomi (borttagande av tjocktarmen) samt följer ett livslångt endoskopisk 
undersökningsprogram.  
 
Det övergripande syftet med avhandlingen var att få en djupare förståelse för hur 
personer med FAP, efter kirurgi, uppfattar att livet är påverkat, för att utifrån resultaten 
utveckla och förbättra vården för dessa personer.  
 
I den första studien genomfördes fokusgruppintervjuer med personer som genomgått 
kirurgi, i åldrarna 18-75 år. Studierna II-IV är tvärsnittsstudier baserade på 
frågeformulärsdata. I Studie II undersöktes gastrointestinala symtom samt hälsostatus 
med frågeformulären Abdominal Symptom Questionnaire (ASQ) och Medical 
Outcomes Study Short Form 36 Health Survey (SF-36). I Studie III, undersöktes 
sjukdomsuppfattning och hälsorelaterad livskvalitet med frågeformulären Revised 
Illness Perception Questionnaire (IPQ-R) och SF-36. I studie IV undersöktes slutligen 
vårdkvalitet med frågeformuläret KUPP- Kvalitet ur patientens perspektiv.  
 
Resultatet från fokusgruppintervjuerna visar att personer med FAP som genomgått 
förebyggande kirurgi anser att livet är påverkat på många sätt. Påverkan på livet var 
relaterat till att FAP är en ärftlig och livslång sjukdom, samt till gastrointestinala 
symtom och en försämrad mag-tarmfunktion efter kirurgi. Vidare visar resultatet att en 
mängd olika strategier för att minska denna påverkan används. Resultat från studien 
som undersökte gastrointestinala symtom visade att 91 % av deltagarna hade haft minst 
ett gastrointestinalt symptom de senaste tre månaderna. Ett medelvärde på 7 (SD 4.61; 
spridning 1-18) symtom rapporterades. Vidare visade studien att ett ökat antal 
gastrointestinala symtom predicerar en sämre fysisk och mental hälsa. Resultat från 
studien som studerade sjukdomsuppfattning visade att FAP anses vara en kronisk 
sjukdom som inte är så lätt att kontrollera. Vidare visade studien att negativa 
konsekvenser av sjukdomen samt ett ökat antal gastrointestinala symtom predicerar 
sämre hälsorelaterad livskvalitet. Studien som studerade vårdkvalitet visade att 
personer som erhåller specialistvård och de med ett lägre antal gastrointestinala 
symtom hade större sannolikhet att vara nöjda med erhållen vård.      
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Sammantaget så visar studierna i avhandlingen på betydelsen av stöd gällande egenvård 
av gastrointestinala symtom samt de negativa konsekvenser som sjukdomen medför. 
Genom att lindra och bota symtom samt genom att minska de negativa konsekvenserna 
av FAP, kan hälsorelaterad livskvalitet hos personer med FAP förbättras. Vidare så bör 
vården för personer med FAP ges av en grupp, specialiserade på FAP, bestående av 
olika professioner och som med fördel kordineras av en sjuksköterska. 
Omhändertagandet bör genomsyras av en holistisk vård, vilket innebär att det är den 
enskilda individen som styr vad som är viktigt för just honom eller henne.  
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